jCyte Revenue and Competitors
Estimated Revenue & Valuation
- jCyte's estimated annual revenue is currently $2M per year.
- jCyte's estimated revenue per employee is $201,500
Employee Data
- jCyte has 10 Employees.
- jCyte grew their employee count by -9% last year.
jCyte's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder & Chief Scientific Officer | Reveal Email/Phone |
3 | President & Co-founder | Reveal Email/Phone |
4 | Chief Scientific Officer & Co-Founder | Reveal Email/Phone |
5 | Chief Strategy Officer and General Counsel | Reveal Email/Phone |
6 | Chief Financial Officer and Treasurer | Reveal Email/Phone |
7 | Chief Development Officer | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Chief Strategy Officer | Reveal Email/Phone |
10 | Chief Medical Officer | Reveal Email/Phone |
jCyte Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is jCyte?
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company's allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jCyte has completed a phase 1/2a, phase 1/2a extension and phase 2b clinical trials testing jCell in patients with Retinitis Pigmentosa.
keywords:N/AN/A
Total Funding
10
Number of Employees
$2M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.3M | 10 | -55% | N/A |
#2 | $0.9M | 10 | 0% | N/A |
#3 | N/A | 10 | -17% | N/A |
#4 | $2.8M | 10 | -23% | N/A |
#5 | $0.5M | 10 | 43% | N/A |